Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells

Japanese Journal of Cancer Research

Volumn 92, Issue 4, 2001, Pages 467-474

  Shinoura, Nobusada ^a,c   Sakurai, Shinya ^a,d   Asai, Akio ^b   Kirino, Takaaki ^b,e   Hamada, Hirofumi ^a,f  

^a CANCER INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apaf 1; Apoptosis; Caspase 9; Etoposide; Glioma

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 9; CELL PROTEIN; ENZYME ACTIVATOR; ETOPOSIDE; MUTANT PROTEIN; PROTEIN BCL XL; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; EVALUATION; GENE; GENE EXPRESSION; GENETIC TRANSDUCTION; GLIOMA CELL; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BCL-X PROTEIN; CASPASE 9; CASPASES; ETOPOSIDE; GENES, P53; GENETIC VECTORS; GLIOMA; HUMANS; MUTATION; PROTEIN BIOSYNTHESIS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035016338     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01117.x     Document Type: Article

References (37)

1. p53 status and the efficacy of cancer therapy in vivo
2. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
3. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents
4. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio
5. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
6. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: Implications for gene therapy
7. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
8. Over-expression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells
9. Oncogene-dependent apoptosis is mediated by caspase-9
10. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
11. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal
12. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
13. Efficient generation of recombinant adenovirus using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome
14. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
15. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: Implications for gene therapy
16. Initiation of Apaf-1 translation by internal ribosome entry
17. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
18. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
19. Caspase-9 and Apaf-1 form an active holoenzyme
20. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
21. Mitochondrial release of caspase-2 and -9 during the apoptotic process
22. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents
23. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis
24. Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and gamma-radiation downstream from caspase-8 activation
25. Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis
26. Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells
27. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis
28. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death
29. L determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax
30. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
31. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway
32. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
33. Betulinic acid triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors
34. STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs
35. Interleukin-1 beta-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells
36. Activation of actin-cleavable interleukin 1 beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells
37. Caspase activation in MCF7 cells responding to etoposide treatment